002604SZSE

Summary of the 2019 Annual Report of Shandong Longli Biological Technology Co., Ltd.

Longli Technology Co., Ltd.··6 pages

✨ AI Summary

This announcement summarizes the 2019 annual report of Shandong Longli Biological Technology Co., Ltd., highlighting significant operational challenges and financial difficulties. The company reported a net loss of approximately 812 million yuan, a 62.66% decrease in revenue compared to the previous year, and a negative net asset value. The board of directors expressed concerns regarding the reliability of financial data due to internal control deficiencies, and the company faces potential delisting risks.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Important Notice

This annual report summary is derived from the full annual report. To fully understand the company's operating results, financial status, and future development plans, investors should carefully read the full annual report published in designated media by the China Securities Regulatory Commission.

Objections from Directors, Supervisors, and Senior Management

NamePositionContent and Reason
Liu BozheDirectorBelieves there are deficiencies in internal control, making it impossible to assess the authenticity of financial data.
Wang KuiqiDirectorBelieves there are deficiencies in internal control, making it impossible to assess the authenticity of financial data.
Nie WeicaiIndependent DirectorBelieves there are deficiencies in internal control, making it impossible to assess the authenticity of financial data.
Ni HaoyanIndependent DirectorBelieves there are deficiencies in internal control, making it impossible to assess the authenticity of financial data.
Pang ShuguangIndependent DirectorElected on June 27, 2019, cannot assess the authenticity of the 2019 annual report's financial data.
Rong HuiSupervisorBelieves there are deficiencies in internal control, making it impossible to assess the authenticity of financial data.

The above individuals cannot guarantee the authenticity, accuracy, and completeness of the financial data in the 2019 annual report, and investors should pay special attention.

Non-standard Audit Opinion

√ Applicable □ Not Applicable Lixin Certified Public Accountants issued an audit report with no opinion for the company. The board of directors and the supervisory board have provided detailed explanations regarding the relevant matters, and investors are advised to read them carefully.

Profit Distribution Plan

The board of directors reviewed the profit distribution plan for ordinary shares during the reporting period: □ Applicable √ Not Applicable The company plans not to distribute cash dividends, issue bonus shares, or increase capital from reserves.

Company Overview

  1. Company Profile

    • Stock Abbreviation: *ST Longli
    • Stock Code: 002604
    • Stock Exchange: Shenzhen Stock Exchange
    • Contact Person: Secretary of the Board
    • Contact Information: Yang Shaode, Yu Yanqi
    • Office Address: National High-tech Industrial Development Zone, Dezhou (Yucheng)
    • Phone: 0534-8103166
    • Email: llgf@longlive.cn
  2. Main Business or Product Overview During the Reporting Period (1) Health Industry: Using corn cobs and corn as raw materials, the company produces functional sugars, starch, and starch sugars through modern biotechnology, and recycles waste from functional sugar production to create second-generation fuel ethanol and other new energy products. (2) Internet Industry: Focused on new media and digital distribution, the company has developed a strong presence in live streaming and e-commerce, with a significant number of followers and marketing accounts.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.